Immediate Impact

2 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update
2024 Standout
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
2 intermediate papers

Works of Briant Fruth being referenced

BACCI: A phase II randomized, double-blind, multicenter, placebo-controlled study of capecitabine (C) bevacizumab (B) plus atezolizumab (A) or placebo (P) in refractory metastatic colorectal cancer (mCRC): An ACCRU network study
2019
A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I
2017

Author Peers

Author Last Decade Papers Cites
Briant Fruth 535 274 142 171 27 754
Sandra J. Casak 433 213 187 143 31 964
Garry Forgeson 485 223 168 171 22 900
Masafumi Takimoto 400 172 126 155 38 805
H.‐G. Mergenthaler 535 206 103 204 33 891
Jacob Colsky 448 174 74 92 40 892
Elaine K. Wong 561 384 58 264 19 910
Yanzhi Hsu 332 416 189 177 41 854
Thomas J. Semrad 387 231 118 98 51 864
Martin Wiesenfeld 621 205 73 136 33 971
Mona Fouad 629 273 95 68 32 879

All Works

Loading papers...

Rankless by CCL
2026